课题基金 / 基金详情

项目摘要

项目成果

Gerald W. Dorn的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):线粒体融合在心肌细胞中的作用存在争议;一些人认为融合在这些细胞中没有作用,在这些细胞中,线粒体的接触受到身体的限制,一些人认为它是严格病理的,因为它促进了SR-线粒体钙转运,打开了线粒体通透性转换孔,还有一些人争辩说,线粒体融合对线粒体健康是必不可少的。目前还没有发表的体内数据来解决这个问题,使用鼠标敲除的未发表的结果也不一致。在这个修订的R21中,我们提出了一些研究,将使用体内线粒体外膜和内膜融合蛋白的遗传操作来确定线粒体融合在果蝇心脏管中的作用。我们将使用心脏基因操作、心脏表型和活的心肌细胞研究的组合,使用我们生成的新的果蝇(果蝇)心肌病模型和荧光蛋白指示剂模型。我们将使用遗传互补,用人有丝分裂素替代被抑制的果蝇线粒体融合蛋白,以询问哺乳动物线粒体融合蛋白的作用。果蝇的心管(在细胞、转录和功能水平上)与哺乳动物的心脏非常相似,可以使用类似的表型技术来分析心脏的结构和功能,从而可以将这种互补/拯救数据外推到高等生物。由于果蝇存活的心脏导管可以在室温和正常大气中保持数小时,因此它们是活体心肌细胞研究的最佳选择。这种机械细胞生物学和完整的心脏生理学的结合在哺乳动物系统中是不可能的。拟议的研究将不会解决一个重要的悬而未决的科学问题,但将为科学界产生新的试剂和技术,从而广泛推进使用果蝇平台的心脏研究。事实上,目前的研究是对果蝇心脏系统假设检验研究能力的雄心勃勃的测试。我们的具体目标是:SA#1.建立具有心脏特异线粒体融合缺陷的新型果蝇遗传模型,类似于我们和其他人正在开发的心脏特异线粒体线粒体融合缺陷小鼠模型。SA#2.开发和部署创新技术,通过使用表达心肌细胞钙信号、线粒体和肌浆网状形态测量和相互作用、ATP/ADP比率、ROS(过氧化氢)产生和线粒体氧化还原电位的基因编码荧光探针的新型苍蝇系,以小鼠模型无法实现的方式分析所产生的心脏表型。
英文摘要
DESCRIPTION (provided by applicant): The role of mitochondrial fusion is disputed in cardiac myocytes; some believe fusion has no role in these cells where mitochondrial contact is enforced by physical constraints, some believe it is strictly pathological because it promotes SR-mitochondrial calcium transport that opens mitochondrial permeability transition pores, and some contest that mitochondrial fusion is essential to mitochondrial health. There are currently no published in vivo data addressing this issue and unpublished results using mouse knockouts are inconsistent. In this revised R21 we propose studies that will use in vivo genetic manipulation of mitochondrial outer and inner membrane fusion proteins to define the role of mitochondrial fusion in Drosophila heart tubes. We will use a combination of cardiac gene manipulation, cardiac phenotyping, and live cardiomyocyte research using new Drosophila melanogaster (fruit fly) cardiomyopathy models and fluorescent protein indicator models that we have generated. We will use genetic complementation, substituting human mitofusins for suppressed Drosophila mitochondrial fusion protein, to interrogate the roles of mammalian mitochondrial fusion proteins. The Drosophila heart tube is (at the cellular, transcriptional, and functional level) sufficiently like the mammalian heart to permit analysis of cardiac structure and function using analogous phenotyping techniques, permitting extrapolation of such complementation/rescue data to higher organisms. Because viable Drosophila heart tubes can be maintained for many hours at room temperature and normal atmosphere, they are optimal for live cardiomyocyte studies. This combination of mechanistic cell biology and intact cardiac physiology is not possible in mammalian systems. The proposed studies will not address an important unanswered scientific question, but will generate new reagents and techniques for the scientific community that will broadly advance cardiac studies using the Drosophila platform. Indeed, the current studies are an ambitious test of the capabilities of hypothesis testing research in the Drosophila cardiac system. Our Specific Aims are: SA#1. Generate novel Drosophila genetic models with cardiac-specific mitochondrial fusion defects analogous to the cardiac-specific mitofusin null mouse models we and others are developing. SA#2. Develop and deploy innovative techniques for analysis of resulting cardiac phenotypes in ways not possible with mouse models through the use of novel fly lines expressing genetically-encoded fluorescent probes for cardiomyocyte calcium signaling, mitochondrial and sarcoplasmic reticular morphometry and interactions, ATP/ADP ratio, ROS (hydrogen peroxide) production, and mitochondrial redox potential.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Mitofusin Agonists to Treat Neurodegenerative Disease
  • 批准号:
    10383118
  • 项目类别:
  • 资助金额:
    $96.87万
  • 财政年份:
    2022
  • 负责人:
    Gerald W. Dorn
  • 依托单位:
Mitofusin Agonists to Treat Neurodegenerative Disease
  • 批准号:
    10618385
  • 项目类别:
  • 资助金额:
    $98.62万
  • 财政年份:
    2022
  • 负责人:
    Gerald W. Dorn
  • 依托单位:
MITOFUSIN AGONISTS TO TREAT NEURODEGENERATIVE DISEASE
  • 批准号:
    10290982
  • 项目类别:
  • 资助金额:
    $7.85万
  • 财政年份:
    2021
  • 负责人:
    Gerald W. Dorn
  • 依托单位:
MITOFUSIN AGONISTS TO TREAT NEURODEGENERATIVE DISEASE
  • 批准号:
    10020801
  • 项目类别:
  • 资助金额:
    $22.47万
  • 财政年份:
    2019
  • 负责人:
    Gerald W. Dorn
  • 依托单位:
海外基金